1. Home
  2. NYXH

NYXH

Nyxoah SA

Logo Nyxoah SA

Health Care

Medical/Dental Instruments

Nasdaq

as 04-18-2024 4:00pm EST

$
-
-
.
-
-
+$
-
.
-
-
+
-
.
-
-
%

Nyxoah SA is a health-technology company focused on the development and commercialization of solutions and services to treat sleep disordered breathing conditions. Nyxoah's solution platform is based on the Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat moderate to severe Obstructive Sleep Apnea (OSA), the common sleep disordered breathing condition that is associated with increased mortality risk and comorbidities including cardiovascular diseases, depression and stroke.

Founded: 2009 Country:
Belgium
Belgium
Employees: N/A City: N/A
Market Cap: 266.7M IPO Year: 2021
Target Price: $18.40 AVG Volume (30 days): 60.5K
Analyst Decision: Strong Buy Number of Analysts: 6
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -1.65 EPS Growth: N/A
52 Week Low/High: $4.00 - $20.00 Next Earning Date: 05-14-2024
Revenue: $4,831,111 Revenue Growth: 40.99%
Revenue Growth (this year): 111.22% Revenue Growth (next year): 280.00%

Share on Social Networks: